Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Perspective · 29 Nov 2022 Research article · 8 May 2023 Use of Antiplatelet and Lipid Lowering Agent Therapies as Primary Cardiovascular Disease Prevention Strategy and their Determinant Factors among Type 2 Diabetes Mellitus Patients in University of Gondar Comprehensive Specialized Hospital, Gondar: A Prospective Cross- Sectional Study
This study aimed to assess the use of antiplatelet and lipid lowering agent therapies as primary cardiovascular disease prevention strategies and their determinant factors among type 2 diabetes mellitus patients…
Perspective · 6 Mar 2023 Impact of the Mitochondrion-Toxic Agents on the Cardiovascular System
Other · 13 Jul 2016 Polypill (fixed-dose combinations) in the prevention of cardiovascular disease: rationale and clinical data
Cardiovascular diseases (CVDs) continue to be major contributors of death and disability globally. Control of CVD risk factors has been shown to be effective in reducing morbidity and mortality both ... individuals at…
Review article · 7 Sep 2019 Do Beta Adrenoceptor Blocking Agents Provide the Same Degree of Clinically Convincing Morbidity and Mortality Benefits in Patients with Chronic Heart Failure
Chronic heart failure has been extensively characterized as a disorder arising from
Research article · 2014 Design, Synthesis and Calcium Channel Blocking Activity of Diltiazem- Verapamil Hybrid Molecules
The current manuscript describes the design, synthesis, and in vitro testing of
Review article · 2014 Cardiovascular Effect of Pyridazine Derivative Pimobedan and Other Related Compounds
various biologically active compounds and some pyridazine compounds have been reported as valuable cardiovascular agents. Benzimidazole-pyridazinone compound, 4,5-dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazole…
Editorial · 1 May 2020 The Atherosclerosis and Lipid Lowering- is there a Need for New Agents
recommended as firstlLne therapy for CVD management. However, a need for other lipid-lowering agents, because some patients do not tolerate statins due to adverse events, or cannot reach ... patients with very high risk…
Perspective · 30 Sep 2024 Vasodilators in Cardiovascular Therapy: From Nitroglycerin to Newer Agents
Article · 1 Dec 2023 Cardiotonic Agents and their Effects on the Rhythmic Resilience of the Heart
Article · 2010 Comparison of risk of neurovascular and cardiovascular side effects between tiotropium and other anticholinergic agents
AimThe aim of this study was to examine the risk of cardiovascular
Conference abstract · 26 Sep 2016 Cardiovascular toxicity by anticancer therapy (chemotherapy, radiotherapy, targeted agents): Utility of early diagnosis and extended cardiological follow up
Anticancer treatment with chemotherapy, radiotherapy and targeted agents can lead to heart
Article · 2012 11. Floating Drug Delivery System a Significant Tool for Stomach Specific Release of Cardiovascular Drugs
into the gastrointestinal tract for the optimization of the pharmacokinetic and toxicological profiles of cardiovascular agents. This review gives an overview of cardiovascular disease, floating drug delivery system &…
Mini review · 29 May 2023 Coexistence of Cardiovascular and Renal Diseases
Cardiorenal multimorbidity, the coexistence of cardiovascular and renal diseases, is a complex
Article · 2 Dec 2019 Evaluation of Pulmonary Arterial Hypertension in Patients with Direct-Acting Antiviral Medications for Hepatitis C Virus Infection andndash; A Prospective Observational Cohort Study
Background: Chronic hepatitis C Virus (HCV) infected patients are at higher risk
Conference abstract · 2016 Photodistributed hyperpigmentation induced by antihypertensive drugs: Two case reports
Antihipertensive drugs induced hyperpigmentation has been rarely described. Calcium channel blockers are commonly prescribed cardiovascular agents and have been associated with skin reactions in sun-exposed areas. No…
Mini review · 30 Sep 2022 Hypertension Clinical Practice Guidelines for Management of High Blood Pressure
Barely any regions are of more noteworthy significance for the wellbeing of
Review article · 9 Mar 2022 Choice and timing of P2Y12 antiplatelet agents in non-STE acute coronary syndrome: A review
Acute coronary syndromes remain a leading cause of morbidity and mortality worldwide
Research article · 26 May 2021 Drug usage pattern in indoor patients of general medicine department at a tertiary care teaching hospital
each patient. 21.07% drugs were prescribed to the age group of 61-70 years. Cardiovascular agents accounted for highest percentage of prescribed drugs (32.71%), followed by 17.92% supplements
Perspective · 25 Feb 2022 Mucormycosis etiological agent rhizopus rhizopodiformis is an emerging etiological agent.
Mucormycosis is caused basically by individuals from the class Rhizopus, particularly R
Review article · 3 Oct 2018 Preclinical Evaluation of Cardiovascular, Hepato-protective, Anti-cancer, Analgesic, Anti-inflammatory and Anti-oxidant Agents Using Animal Models: An Over View
It is very important for an innovator to select appropriate animal models
Conference abstract · 19 Jun 2017 Effect of chronic hepatitis C virus treatment by combination therapy on cardiovascular system
impressive results. Aim: Aim of this study is to assess the cardiovascular effects of direct acting antiviral agents (DAAs) in combination with or without pegylated interferon alpha ... direct antiviral agents used in…

